Imieliński Lab
The Imieliński Lab applies cancer genome assembly and long molecule sequencing to study the chromosomal structure of DNA in cancer. The lab develops new algorithms and genomic assays, and applies them to clinical samples to gain basic and clinical insight into cancer progression. A basic goal of the lab is to understand how complex somatic DNA rearrangements shape the tumor epigenome, and vice versa. More fundamentally, the lab is interested in using structural variation as a lens to study mutational processes that drive somatic evolution, from pre-cancer to metastasis. The lab is committed to translating clinically relevant basic research findings into genomic diagnostics and incorporating these into precision cancer care. This includes the imminent application of clinical cancer whole genome sequencing as the “iPhone” of precision oncology diagnostics.
Marcin Imieliński, MD, PhD
Core Faculty Member, NYGC
Associate Professor, Department of Pathology at NYU Grossman School of Medicine; Director Cancer Genomics Research Program, NYU Langone
Latest News & Publications
-
Nature Genetics · November 9, 2023
-
bioRxiv · October 17, 2023 · Preprint
Detecting significantly recurrent genomic connections from simple and complex rearrangements in the cancer genome.
-
bioRxiv · October 12, 2023 · Preprint
A sequence context-based germline filter for structural variant calling from tumor samples without paired normal.